Pulse Biosciences (NASDAQ:PLSE) vs. Paradigm Medical Industries (OTCMKTS:PDMI) Head-To-Head Analysis

Paradigm Medical Industries (OTCMKTS:PDMI) and Pulse Biosciences (NASDAQ:PLSE) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Earnings & Valuation

This table compares Paradigm Medical Industries and Pulse Biosciences”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Paradigm Medical Industries	N/A	N/A	N/A	N/A	N/A
Pulse Biosciences	$350,000.00	5,204.59	-$72.78 million	($1.10)	-23.93

Paradigm Medical Industries has higher earnings, but lower revenue than Pulse Biosciences.

Profitability

This table compares Paradigm Medical Industries and Pulse Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Paradigm Medical Industries	N/A	N/A	N/A
Pulse Biosciences	N/A	-86.67%	-73.61%

Risk & Volatility

Paradigm Medical Industries has a beta of -1.62, meaning that its share price is 262% less volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500.

Institutional & Insider Ownership

77.0% of Pulse Biosciences shares are owned by institutional investors. 11.1% of Paradigm Medical Industries shares are owned by company insiders. Comparatively, 74.0% of Pulse Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Paradigm Medical Industries and Pulse Biosciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Paradigm Medical Industries	0	0	0	0	0.00
Pulse Biosciences	1	0	3	0	2.50

Pulse Biosciences has a consensus target price of $30.67, indicating a potential upside of 16.51%. Given Pulse Biosciences’ stronger consensus rating and higher probable upside, analysts clearly believe Pulse Biosciences is more favorable than Paradigm Medical Industries.

Summary

Pulse Biosciences beats Paradigm Medical Industries on 7 of the 9 factors compared between the two stocks.

About Paradigm Medical Industries

Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.

About Pulse Biosciences

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.